NFKB1 and cancer: The tumorigenic roles of NF-κB in lung and other cancers are largely derived from the antitumor effects of NF-κB inhibition by administration of IKK inhibitors, overexpression of the NF-κB inhibitor IκBα, and the knockout/knockdown of IKK or RelA (1, 2, 8–14).